MAPT and Huntington disease: Interestingly, in the large cohort, levels of T-tau proteins in the prefrontal cortex of HD patients were 53% lower than in non-HD individuals (Fig. 2a and b, Table 3), indicating that the elevated levels of Δtau314 proteins in HD patients were not due to an overall increase in T-tau proteins.